Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

145546-80-1

Donepezil Related Compound A

145546-80-1
120013-39-0

Desbenzyl donepezil HCl

120013-39-0
197010-25-6

2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic Acid

197010-25-6
120013-84-5

rac-(cis/trans) Donepezil N-Oxide

120013-84-5
1034439-57-0

Deoxy Donepezil HCl

1034439-57-0
844694-85-5

Donepezil Benzyl Bromide

844694-85-5
120013-45-8

Dehydrodeoxy Donepezil

120013-45-8
197010-20-1

Hydroxy Donepezil

197010-20-1
NA

Desisobutyl-benzylsibutramineHCl

NA
4101-80-8

Dichloroisoeverninic acid

4101-80-8
103337-71-9

Diclazuril-methyl

103337-71-9
59198-70-8

Diflucortolone 21-Valerate

59198-70-8
1173021-89-0

Difloxacin D3 HCl 3H2O

1173021-89-0
56-53-1

Diethylstilbestrol

56-53-1
312-93-6

Dexamethasone phosphate

312-93-6
78213-16-8

Diclofenac diethylamine

78213-16-8
54573-75-0

Doxercalciferol

54573-75-0
114977-28-5

Docetaxel

114977-28-5
138-14-7

Deferoxamine mesilate

138-14-7
9006-65-9

Dimethicone

9006-65-9